Grifols (GIFLF) EBT Margin Growth (3y) (2013 - 2024)
Powered by 
Analysis
Grifols (GIFLF) EBT Margin Growth (3y) (2013 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 443.00 |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -15,548.00 |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | -484.00 |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 132.00 |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 6,691.00 |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | -2,054.00 |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 9,980.00 |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -2,399.00 |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -1.89 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 50,170.00 |
| Dec 31, 2021 | -50,308.00 |
| Dec 31, 2020 | -55,864.00 |
| Mar 31, 2020 | 217.00 |
| Dec 31, 2019 | 1,387.00 |
| Mar 31, 2019 | -1,711.00 |
| Dec 31, 2018 | 2,053.00 |
| Jun 30, 2018 | 24.00 |
| Mar 31, 2018 | -853.00 |
| Dec 31, 2017 | 1,144.00 |
| Jun 30, 2017 | 870.00 |
| Mar 31, 2017 | -1,080.00 |
| Dec 31, 2016 | -69,061.00 |
| Sep 30, 2016 | 512.00 |
| Jun 30, 2016 | 395.00 |
| Mar 31, 2016 | 1,114.00 |
| Dec 31, 2015 | -52,080.00 |
| Sep 30, 2015 | 1,040.00 |
| Jun 30, 2015 | 801.00 |
| Mar 31, 2015 | 1,059.00 |